The global dry eye disease market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the rising prevalence of aging population and increasing incidences of ocular surface diseases. The other factor that is anticipated to fuel the market growth includes the increasing usage of the computer or digital screens may cause less blinking, which may contribute to symptoms of dry eye disease. The majority of the population uses computers and even more of them constantly deal with smartphones, digital devices, and tablet computers. A significant percentage of the global population (middle age to older age) suffers from dry eye disease. The disease is particularly more common among women than in men. According to the World Ageing 2019 report, there were about 703 million population aged 65 years or over in the world in 2019. This number is projected to double to 1.5 billion in 2050. As the number of the elderly population is projected to increase, eye-related disorders, such as dry eye will increase, which ultimately drives the market growth in the near future.
To Request a Sample of our Report on Global Dry Eye Disease Market: https://www.omrglobal.com/request-sample/dry-eye-disease-market-size
In June 2021, Kala Pharmaceuticals. launched Eysuvis, short-term treatment of dry eye disease. Eysuvis uses Kala’s proprietary Ampplify mucus-penetrating particle drug delivery technology for enhanced penetration of loteprednol etabonate into target ocular surface tissue to treat signs and symptoms of dry eye disease. In October 2019, Sun Pharmaceutical Industries Ltd. launched CEQUA for the treatment of Dry Eye Disease in the US. CEQUA 0.09% for topical ophthalmic use is the first and only approved cyclosporine treatment delivered with NCELL technology. However, the high cost of specialty dry eye products with complex reimbursement scenarios and availability of alternative therapies is likely to limit the market growth during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Alcon Vision LLC, Bausch Health Companies Inc., and AbbVie Inc., among others.
A full Report of Global Dry Eye Disease Market is Available @ https://www.omrglobal.com/industry-reports/dry-eye-disease-market-size
Global Dry Eye Disease Market Report by Segment
By Product
- Artificial Tears
- Anti-inflammatory Drugs
- Punctal Plugs
- Secretagogues
- Others
By Distribution Channel
- Hospital Pharmacies
- Independent Pharmacies and Drug Stores
- Online Pharmacies
Global Dry Eye Disease Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dry-eye-disease-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
